Фоновый узор

Piperacilina/tazobactam aurovitas 2 g/0,25 g polvo para solucion para perfusion efg

О препарате

Introduction

Prospecto: Information for the user

Piperacilina/Tazobactam Aurovitas 2 g/0.25 g powder for solution for infusion EFG

Read this prospect carefully before starting to take this medicine, because it contains important information for you.

-Keep this prospect, as you may need to read it again.

-If you have any doubts, consult your doctor, pharmacist, or nurse.

-This medicine has been prescribed only for you, and you should not give it to other people even if they have the same symptoms as you, as it may harm them.

-If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this prospect. See section 4.

1.What is Piperacilina/Tazobactam Aurovitas and what is it used for

2.What you need to know before starting to use Piperacilina/Tazobactam Aurovitas

3.How to use Piperacilina/Tazobactam Aurovitas

4.Possible adverse effects

5.Storage of Piperacilina/Tazobactam Aurovitas

6.Contents of the package and additional information

1. What is Piperacilina/Tazobactam Aurovitas and how is it used

Piperacilina belongs to a group of medicines called “broad-spectrum penicillin antibiotics” and can destroy many types of bacteria. Tazobactam may prevent some resistant bacteria from surviving the effects of piperacilina. In this way, by administering piperacilina and tazobactam concurrently, more types of bacteria are destroyed.

Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold.

It is essential that you follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after treatment, return it to the pharmacy for proper disposal. Do not dispose of the medication through the drain or in the trash.

Piperacilina/tazobactam is used in adults and adolescents to treat bacterial infections, such as those affecting the lower respiratory tract (lungs), urinary tract (kidneys and bladder), abdomen, skin, or blood. Piperacilina/tazobactam may be used to treat bacterial infections in patients with low white blood cell counts (reduced resistance to infections).

Piperacilina/tazobactam is used in children between 2 and 12 years old to treat abdominal infections, such as appendicitis, peritonitis (infection of the abdominal fluid and lining of abdominal organs), and gallbladder infections. Piperacilina/tazobactam may be used to treat bacterial infections in patients with low white blood cell counts (reduced resistance to infections).

In certain severe infections, your doctor may consider using piperacilina/tazobactam in combination with otherantibiotics.

2. What you need to know before starting to use Piperacillin/Tazobactam Aurovitas

No use Piperacilina/TazobactamAurovitas

-if you are allergic to piperacillin, tazobactam, or any of the other components of this medication (listed in section 6).

-if you are allergic to antibiotics called penicillins, cephalosporins, or other beta-lactamase inhibitors, as you may be allergic to piperacillin/tazobactam.

Warnings and Precautions

Consult your doctor, pharmacist, or nurse before starting to use Piperacilina/Tazobactam Aurovitas:

-if you have allergies. If you have multiple allergies, make sure to tell your doctor or another healthcare professional before receiving this medication.

-if you had diarrhea before treatment or if you start having diarrhea during or after treatment. In this case, make sure to tell your doctor or another healthcare professional immediately. Do not take any medication for diarrhea without consulting your doctor first.

-if you have low potassium levels in your blood. Your doctor may want to examine your kidneys before giving you this medication and may perform blood tests periodically during treatment.

-if you have kidney or liver problems, or are receiving hemodialysis. Your doctor may want to check your kidneys before giving you this medication and may perform blood tests periodically during treatment.

-if you are using another antibiotic called vancomycin at the same time as piperacillin/tazobactam, it may increase the risk of kidney damage (see alsoOther Medications and Piperacilina/Tazobactam Aurovitasin this prospectus).

-if you are using certain medications (called anticoagulants) to prevent excessive blood clotting (see alsoOther Medications and Piperacilina/Tazobactam Aurovitasin this prospectus) or if you experience unexpected bleeding during treatment. In this case, you must inform your doctor or another healthcare professional immediately.

-if you experience seizures during treatment. In this case, you must inform your doctor or another healthcare professional immediately.

-if you think you have developed a new infection or if your infection has worsened. In this case, you must inform your doctor or another healthcare professional immediately.

Hemophagocytic Lymphohistiocytosis

Cases of a disease in which the immune system produces too many normal white blood cells called histiocytes and lymphocytes, causing inflammation (hemophagocytic lymphohistiocytosis) have been reported. This disease can be potentially fatal if not diagnosed and treated promptly. If you experience multiple symptoms such as fever, swelling of lymph nodes, feeling weak, feeling dizzy, difficulty breathing, bruises, or skin rash, contact your doctor immediately.

Children under 2 years

Piperacillin/tazobactam is not recommended for children under 2 years due to a lack of data on safety and efficacy.

Other Medications and Piperacilina/Tazobactam Aurovitas

Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, including those purchased without a prescription..

Some medications may interact with piperacillin or tazobactam. These include:

-a medication for gout (probenecid). This medication may increase the time it takes for piperacillin and tazobactam to be eliminated from the body.

-medications used to thin the blood or to treat blood clots (e.g., heparin, warfarin, or aspirin).

-medications used to relax muscles during surgery. Inform your doctor if you are going to undergo general anesthesia.

-methotrexate (a medication used to treat cancer, arthritis, or psoriasis). Piperacillin and tazobactam may increase the time it takes for methotrexate to be eliminated from the body.

-medications that lower potassium levels in the blood (e.g., diuretics or some cancer medications).

-medications that contain other antibiotics such as tobramycin, gentamicin, or vancomycin.

-Inform your doctor if you have kidney problems.The use of piperacillin/tazobactam and vancomycin at the same time may increase the risk of kidney damage, even if you do not have kidney problems.

Laboratory Test Effects

If you need to provide a blood or urine sample, tell your doctor or laboratory staff that you are using piperacillin/tazobactam.

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Your doctor will decide if piperacillin/tazobactam is suitable for you.

Piperacillin and tazobactam may pass into the fetus or through breast milk. If you are breastfeeding, your doctor will decide if piperacillin/tazobactam is suitable for you.

Driving and Operating Machines

The use of piperacillin/tazobactam is not expected to affect your ability to drive or operate machines.

Piperacilina/Tazobactam Aurovitas contains sodium

This medication contains 108 mg of sodium (main component of table salt/for cooking) in each vial. This is equivalent to 5.4% of the maximum daily sodium intake recommended for an adult.This should be taken into account in patients with low-sodium diets.

3. How to Use Piperacilina/Tazobactam Aurovitas

Your doctor or another healthcare professional will administer this medication through intravenous infusion (into a vein with a drip over 30 minutes).

Dosage

The dose of medication you receive will depend on what you are being treated for, your age, and whether you have any kidney problems.

Adults and adolescents 12 years of age or older

The usual dose is 4 g/0.5 g of piperacilina/tazobactam administered every 6-8 hours through a vein (directly into the bloodstream).

Children 2 to 12 years of age

The usual dose for children with abdominal infections is 100 mg/12.5 mg/kg of body weight of piperacilina/tazobactam administered every 8 hours through a vein (directly into the bloodstream). The usual dose for children with low white blood cell counts is 80 mg/10 mg/kg of body weight of piperacilina/tazobactam administered every 6 hours through a vein (directly into the bloodstream).

Your doctor will calculate the dose based on the child's weight, but each individual dose will not exceed 4 g/0.5 g of piperacilina/tazobactam.

You will be given piperacilina/tazobactam until the signs of infection have completely disappeared (5 to 14 days).

Patients with kidney problems

Your doctor may need to reduce the dose of piperacilina/tazobactam or the frequency of administration. Your doctor may also want to perform blood tests to ensure you receive the correct dose of treatment, especially if you need to use this medication for a long time.

If you use more Piperacilina/Tazobactam Aurovitas than you should

Since a doctor or another healthcare professional will administer piperacilina/tazobactam, it is unlikely that you will receive an incorrect dose. However, if you experience side effects such as seizures, or think you have been given too much medication, tell your doctor immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount administered.

If you forgot to use Piperacilina/Tazobactam Aurovitas

If you think you have not received a dose of piperacilina/tazobactam, tell your doctor or another healthcare professional immediately.

If you have any other questions about using this medication, ask your doctor or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Consult your doctor immediatelyif you experience any of these potentially serious side effects of piperacilina/tazobactam.

The serious side effects (frequency in parentheses) of piperacilina/tazobactam are:

-severe skin eruptions [(Stevens-Johnson syndrome, bullous dermatitis (unknown frequency), exfoliative dermatitis (unknown frequency), toxic epidermal necrolysis (rare)] that initially appear on the trunk as red spots with a bull's-eye shape or circular spots with central blisters. Other signs include mouth ulcers, throat, nose, limbs, genital, and conjunctivitis (red and swollen eyes). The rash may progress to blistering or generalized skin peeling and, potentially, can be fatal.

-potentially fatal severe allergic reaction (medication reaction with eosinophilia and systemic symptoms) that may affect the skin and other major organs of the body such as the kidneys or liver.

-a skin disease (acute generalized pustular psoriasis) accompanied by fever, consisting of numerous small pustules filled with liquid that appear on large areas of swollen and red skin.

-swelling of the face, lips, tongue, or other parts of the body (unknown frequency).

-shortness of breath, wheezing, or difficulty breathing (unknown frequency).

-severe skin rash or urticaria on the skin (rare), itching or skin rash (frequent).

-yellowing of the eyes and skin (unknown frequency).

-blood cell damage [symptoms include: shortness of breath when not expected, urine that is red or brown (unknown frequency), nasal bleeding (rare), small hematomas (unknown frequency), severe decrease in white blood cells in the blood (rare)].

-severe or persistent diarrhea accompanied by fever or weakness (rare).

If any ofthe followingside effects are severe or if you experience any side effect not mentioned in this information leaflet, inform your doctor or another healthcare professional.

Very common side effects(may affect more than 1 in 10 people)

-diarrhea.

Common side effects(may affect up to 1 in 10 people)

-yeast infection.

-decrease in platelets, decrease in red blood cells or hemoglobin (blood pigment), abnormal laboratory tests (direct Coombs test positive), prolonged blood clotting time (activated partial thromboplastin time prolonged).

-decrease in blood proteins.

-headache, insomnia.

-abdominal pain, vomiting, nausea, constipation, stomach discomfort.

-increase in liver enzymes in the blood.

-skin eruptions, itching.

-abnormal kidney function tests.

-fever, reaction at the injection site.

Rare side effects(may affect up to 1 in 1,000 people)

-severe decrease in white blood cells (agranulocytosis), nasal bleeding.

-severe colon infection, inflammation of the mucous membrane of the mouth.

-peeling of the skin on the entire body (toxic epidermal necrolysis).

Side effects of unknown frequency(cannot be estimated from available data)

-severe decrease in red blood cells, white blood cells, and platelets (pancytopenia), severe decrease in white blood cells (neutropenia), decrease in red blood cells due to premature rupture or degradation, small hematomas, prolonged bleeding time, increase in platelets, increase in a specific type of white blood cells (eosinophilia).

-severe allergic reaction and severe allergic reaction.

-inflammation of the liver, yellowing of the skin or white of the eyes.

-severe allergic reaction throughout the body with skin exanthema and mucosa, blisters, and multiple skin eruptions (Stevens-Johnson syndrome), severe allergic reactions affecting the skin and other organs such as the kidneys and liver (medication reaction with eosinophilia and systemic symptoms), numerous small pustules filled with liquid that appear on large areas of swollen and red skin accompanied by fever (acute generalized pustular psoriasis), skin eruptions with blisters (bullous dermatitis).

-renal function impairment and kidney problems.

-a type of lung disease where eosinophils (a type of white blood cell) appear in the lung in greater numbers.

-acute disorientation and confusion (delirium).

In patients with cystic fibrosis, treatment with piperacilina has been associated with an increased incidence of fever and skin eruptions.

The beta-lactam antibiotics, including piperacilina/tazobactam, may lead tosigns of alteredbrain function(encephalopathy) and convulsions.

Reporting of side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this information leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Piperacillin/Tazobactam Aurovitas

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and on the vial label after CAD. The expiration date is the last day of the month indicated.

Powder:

Unopened vials: Store below 25°C.

For single use. Discard unused solution.

The reconstituted/diluted medication solutions are physically compatible and chemically stable for 24 hours at controlled room temperature (25°C) and 48 hours at 2-8°C.

From a microbiological standpoint, reconstituted and diluted solutions should be used immediately. If not used immediately, storage times and conditions before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless reconstitution and dilution have taken place in controlled and validated aseptic conditions.

Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of empty containers and unused medications. This will help protect the environment.

6. Contents of the packaging and additional information

Piperacilina/Tazobactam Aurovitas Composition

-The active ingredients are piperacilina and tazobactam. Each vial contains 2 g of piperacilina (in the form of sodium salt) and 0.25 g of tazobactam (in the form of sodium salt).

-There are no more components.

Appearance of the product and contents of the package

White to off-white powder for solution for infusion.

Piperacilina/Tazobactam Aurovitas is available in packs of 1, 10 or 12 vials conditioned in cardboard boxes with a leaflet.

Only some package sizes may be marketed.

Marketing Authorization Holder and Responsible Manufacturer

Marketing Authorization Holder:

Eugia Pharma (Malta) Limited

Vault 14, Level 2, Valletta Waterfront

Floriana, FRN 1914

Malta

Responsible Manufacturer:

APL Swift Services (Malta) Limited

HF26, Hal Far Industrial Estate, Hal Far

Birzebbugia, BBG 3000

Malta

For more information about this medicine, please contact the local representative of the marketing authorization holder:

Aurovitas Spain, S.A.U.

Avda. de Burgos, 16-D

28036 Madrid

Spain

Last review date of this leaflet:December 2022

The detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es).

This information is intended only for medical professionals or healthcare professionals:

Nota: no se recomienda el uso para bacteriemia debida aE. coliyK. pneumoniae(no sensible a ceftriaxona) productoras de betalactamasa de espectro extendido (BLEE) en pacientes adultos.

Piperacilina/Tazobactam Aurovitas 2 g/0.25 g powder for solution for infusion EFG

The following text is an extract from the Technical Dossier that serves as a guide for the administration of Piperacilina/Tazobactam Aurovitas. The prescribing physician must be familiar with the Technical Dossier to determine the suitability of use in a specific patient.

For intravenous infusion.

Incompatibilities with diluents and other medicines

The Ringer Lactate (Hartmann) solution is not compatible with piperacilina/tazobactam.

When used concomitantly with other antibiotics (e.g. aminoglucosides), piperacilina/tazobactam should be administered separately. The mixture of piperacilina/tazobactam with an aminoglucoside in vitro may cause inactivation of the aminoglucoside.

Piperacilina/tazobactam should not be mixed with other medicines in a syringe or glass bottle for infusion, as compatibility has not been established.

Due to chemical instability, piperacilina/tazobactam should not be used in solutions containing sodium bicarbonate.

Piperacilina/tazobactam should not be added to products containing blood or hydrolyzed albumin.

Instructions for use, handling and disposal

The reconstitution and dilution should be performed in aseptic conditions.Before administration, the solution should be visually inspected for particles and color change. Only the solution should be used if it is transparent and free of particles.

Instructions for inserting the needle into the rubber stopper

To prevent the rubber stopper from being dislodged when inserting the needle into the rubber stopper, it is recommended to use a needle with an outer diameter of 0.8 mm or less for reconstituting the medicine.

The needle should be inserted only in the center of the rubber stopper, vertically.

For single use only. Discard the unused solution.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

Sterile diluents for preparing the reconstituted solution

Sterile water for injection preparations.

Injectable solution of sodium chloride 9 mg/ml (0.9%).

Glucose 50 mg/ml (5%) in water for injection preparations.

Glucose 50 mg/ml (5%) in injectable solution of sodium chloride 9 mg/ml (0.9%).

Instructions for dilution (for intravenous infusion)

Each vial of piperacilina/tazobactam 2 g/0.25 g should be reconstituted with 10 ml of the above diluents.

Shake until complete dissolution.

The reconstituted solutions can be diluted further to the concentration range of 13.33/1.67 mg/ml to 80/10 mg/ml with the following diluents:

Sterile water for injection preparations.

Injectable solution of sodium chloride 9 mg/ml (0.9%).

Glucose 50 mg/ml (5%) in water for injection preparations.

Glucose 5% in injectable solution of sodium chloride 0.9%.

Special storage conditions

Vials not opened:Store below 25°C.

The reconstituted/diluted solutions of the medicine are physically compatible and chemically stable for 24 hours at controlled room temperature (25°C) and 48 hours at 2-8°C.

From a microbiological point of view, the reconstituted and diluted solutions should be used immediately. If not used immediately, the storage times and conditions before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless reconstitution and dilution have taken place in controlled and validated aseptic conditions.

Страна регистрации
Активное вещество
Требуется рецепт
Да
Производитель
Состав
Hidrogeno carbonato de sodio (162,300 mg mg), Hidrogeno carbonato de sodio (162,300 mg mg), Hidrogeno carbonato de sodio (69,930 mg mg)
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.

Общайтесь с врачом онлайн

Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.

5.01 отзыв
Doctor

Anna Moret

Dermatology18 лет опыта

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

Записаться на онлайн-консультацию
5.01 отзыв
Doctor

Alina Tsurkan

Family Medicine12 лет опыта

Dr. Alina Tsurkan is a licensed family medicine doctor based in Portugal. She provides personalised primary care for both adults and children, helping patients manage a wide range of everyday health concerns with professionalism and attention to detail.

Dr. Tsurkan diagnoses and treats common conditions such as: • Respiratory infections (cold, flu, bronchitis, pneumonia) • Eye conditions: conjunctivitis (infectious and allergic) • ENT problems (sinusitis, ear infections, tonsillitis) • Digestive issues including gastritis, acid reflux, and IBS • Urinary tract infections and other frequent infections • Chronic conditions such as high blood pressure, diabetes, and thyroid disorders • Headaches and migraines

In addition to symptom-based care, Dr. Tsurkan focuses on prevention and early detection. She offers regular health check-ups, follow-up care, and medical prescriptions tailored to each patient’s needs.

With a comprehensive and caring approach, Dr. Tsurkan supports patients at every stage of life — from acute illnesses to long-term health management.

Записаться на онлайн-консультацию
5.09 отзывов
Doctor

Andrei Popov

General Medicine6 лет опыта

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Записаться на онлайн-консультацию
5.01 отзыв
Doctor

Yevgen Yakovenko

General Surgery11 лет опыта

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain, with a diverse clinical background in general and pediatric surgery, internal medicine, and pain management. With a strong focus on both practice and research, he provides comprehensive medical consultations for adults and children, covering both surgical and therapeutic needs.

Dr. Yakovenko offers expert care in the following areas: • Diagnosis and treatment of acute and chronic pain • Pre- and postoperative care, including risk assessment and follow-up • Surgical conditions such as hernias, gallbladder disease, and appendicitis • Pediatric surgery consultations, including congenital conditions and minor procedures • Trauma care: fractures, soft tissue injuries, and wound management • Oncological surgery consultation and post-treatment care • Cardiovascular and respiratory conditions (internal medicine) • Orthopedic concerns and post-trauma rehabilitation • Radiological interpretation for surgical planning

In addition to his clinical work, Dr. Yakovenko actively participates in medical research and international collaboration. He is a member of the German Surgeons Association (BDC), affiliated with the General Practitioners Association of Las Palmas, and works with the German Consulate in the Canary Islands. He regularly attends international medical conferences and has authored scientific publications.

With over a decade of multidisciplinary experience, Dr. Yakovenko delivers precise, evidence-based care tailored to each patient’s needs.

Записаться на онлайн-консультацию
Смотреть всех врачей

Следите за новостями и экономьте на услугах

Советы врачей, обновления платформы и скидки для подписчиков.

Следите за нами в соцсетях